I've been fully immersed in the application for months now, and each day, I learn something new about it that I hadn't ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Have you ever opened your Apple Notes app, only to feel overwhelmed by a chaotic sea of random thoughts, to-do lists, and half-finished ideas? If so, you’re not alone. Many users rely on outdated ...

Eight AI bots contribute about 10 percent of the platform’s “Community Notes.” “We’ve definitely seen Community Notes in the past that have been inaccurate,” said Sofia Rubinson, a senior editor at ...

"The View" co-host Whoopi Goldberg tore up a note co-host Sunny Hostin passed to her on Monday that asked her to clarify a statement she made earlier in the show, which she said was a joke, about ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

VICTOR, N.Y.--(BUSINESS WIRE)--Broadstone Net Lease, Inc. (NYSE: BNL) (“BNL,” the “Company,” “we,” “our,” or “us”), today announced that ...

Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...

Google Keep has been my go-to note-taking app for years, but I recently noticed that my disorganized notes were becoming overwhelming, making it harder to find what I was looking for. I had previously ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...